EUVIMEDEUVIMED entdecken
Crossref

Disease-Inspired Design of Biomimetic Tannic Acid–Based Hybrid Nanocarriers for Enhancing the Treatment of Bacterial-Induced Sepsis

Eman Elhassan, Calvin A Omolo iD, Mohammed Ali Gafar, Lucy W Kiruri, Usri H Ibrahim, Eman A Ismail, Nikita Devnarain, Thirumala Govender iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Eman Elhassan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal, Private Bag Durban X54001, South Africa. Hauptthemen laut MEDLINE: Tannins, Sepsis, Anti-Bacterial Agents, Drug Carriers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 135 Literaturangaben. Gefördert von: Medical Research Council (MRC), Inyuvesi Yakwazulu-Natali, National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explored the development of novel biomimetic tannic acid-based hybrid nanocarriers (HNs) for targeted delivery of ciprofloxacin (CIP-loaded TAH-NPs) against bacterial-induced sepsis. The prepared CIP-loaded TAH-NPs exhibited appropriate physicochemical characteristics and demonstrated biocompatibility and nonhemolytic properties. Computational simulations and microscale thermophoresis studies validated the strong binding affinity of tannic acid (TA) and its nanoformulation to human Toll-like receptor 4, surpassing that of the natural substrate lipopolysaccharide (LPS), suggesting a potential competitive inhibition against LPS-induced inflammatory responses. CIP released from TAH-NPs displayed a sustained release profile over 72 h. The in vitro antibacterial activity studies revealed that CIP-loaded TAH-NPs exhibited enhanced antibacterial efficacy and efflux pump inhibitory activity. Specifically, they showed a 3-fold increase in biofilm eradication activity against MRSA and a 2-fold increase against P. aeruginosa compared to bare CIP. Time-killing assays demonstrated complete bacterial clearance within 8 h of treatment with CIP-loaded TAH-NPs. In vitro DPPH scavenging and anti-inflammatory investigations confirmed the ability of the prepared hybrid nanosystem to neutralize reactive oxygen species (ROS) and modulate LPS-induced inflammatory responses. Collectively, these results suggest that CIP-loaded TAH-NPs may serve as an innovative nanocarrier for the effective and targeted delivery of antibiotics against bacterial-induced sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TanninsSepsisAnti-Bacterial AgentsDrug CarriersCiprofloxacinNanoparticlesHumansPseudomonas aeruginosaAnimalsBiofilmsMiceMicrobial Sensitivity TestsMethicillin-Resistant Staphylococcus aureusLipopolysaccharidesDrug LiberationBiomimeticsReactive Oxygen SpeciesToll-Like Receptor 4Polyphenols

Stichwörter der Autor:innen

TLR4 antagonismantibiotic deliverybacterial sepsisbiomimetichybrid nanocarrierstannic acid

Substanzen

TanninsAnti-Bacterial AgentsDrug CarriersCiprofloxacinLipopolysaccharidesReactive Oxygen SpeciesToll-Like Receptor 4tannic acidPolyphenols

Autor:innen und Institutionen

  • Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal, Private Bag Durban X54001, South Africa.
  • Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy and Health Sciences, United States International University-Africa, P.O. Box 14634-00800, Nairobi 00800, Kenya.
  • Department of Pharmaceutics, Faculty of Pharmacy, University of Khartoum, Khartoum 11111, Sudan.
  • Department of Chemistry, Kenyatta University, P.O. Box 43844, Nairobi 00100, Kenya.
  • Discipline of Human Physiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4300, South Africa.

ORCID-Profile: Calvin A Omolo, Thirumala Govender

Förderung

  • Medical Research Council (MRC)
  • Inyuvesi Yakwazulu-Natali
  • National Research Foundation

Zitieren

APA

Elhassan, E., Omolo, C. A., Gafar, M. A., Kiruri, L. W., Ibrahim, U. H., Ismail, E. A., Devnarain, N., & Govender, T. (2024). Disease-Inspired Design of Biomimetic Tannic Acid–Based Hybrid Nanocarriers for Enhancing the Treatment of Bacterial-Induced Sepsis. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00048

Vancouver

Elhassan E, Omolo CA, Gafar MA, Kiruri LW, Ibrahim UH, Ismail EA, et al. Disease-Inspired Design of Biomimetic Tannic Acid–Based Hybrid Nanocarriers for Enhancing the Treatment of Bacterial-Induced Sepsis. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00048

BibTeX
@article{Elhassan2024,
  author = {Elhassan, Eman and Omolo, Calvin A and Gafar, Mohammed Ali and Kiruri, Lucy W and Ibrahim, Usri H and Ismail, Eman A and Devnarain, Nikita and Govender, Thirumala},
  title = {Disease-Inspired Design of Biomimetic Tannic Acid–Based Hybrid Nanocarriers for Enhancing the Treatment of Bacterial-Induced Sepsis},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00048}
}
Kostenlos starten →